Tongyang Life Net Assets
Tongyang Life net assets. Based on the latest financial reports, Tongyang Life (082640) has net assets worth ₩2.34 Trillion KRW (≈ $1.58 Billion USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩35.29 Trillion ≈ $23.91 Billion USD) and total liabilities (₩32.95 Trillion ≈ $22.33 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 082640 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩2.34 Trillion |
| % of Total Assets | 6.62% |
| Annual Growth Rate | 5.98% |
| 5-Year Change | -49.12% |
| 10-Year Change | -15.63% |
| Growth Volatility | 27.3 |
Net Assets of Tongyang Life (2007–2025)
Net assets of Tongyang Life from 2007 to 2025. This chart illustrates how Tongyang Life's net assets have evolved over time, based on quarterly financial data. See debt-free asset ratio of Tongyang Life to measure how much of total assets are equity-financed.
Annual Net Assets for Tongyang Life (2007–2025)
The table below shows the annual net assets of Tongyang Life from 2007 to 2025. For live market cap and overall valuation, see Tongyang Life market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩1.55 Trillion ≈ $1.05 Billion |
-21.34% |
| 2024-12-31 | ₩1.97 Trillion ≈ $1.33 Billion |
-32.19% |
| 2023-12-31 | ₩2.90 Trillion ≈ $1.97 Billion |
-40.24% |
| 2022-12-31 | ₩4.86 Trillion ≈ $3.29 Billion |
+59.65% |
| 2021-12-31 | ₩3.04 Trillion ≈ $2.06 Billion |
-1.57% |
| 2020-12-31 | ₩3.09 Trillion ≈ $2.10 Billion |
+18.89% |
| 2019-12-31 | ₩2.60 Trillion ≈ $1.76 Billion |
+13.23% |
| 2018-12-31 | ₩2.30 Trillion ≈ $1.56 Billion |
-6.33% |
| 2017-12-31 | ₩2.45 Trillion ≈ $1.66 Billion |
+33.59% |
| 2016-12-31 | ₩1.84 Trillion ≈ $1.24 Billion |
-7.88% |
| 2015-12-31 | ₩1.99 Trillion ≈ $1.35 Billion |
+10.34% |
| 2014-12-31 | ₩1.81 Trillion ≈ $1.22 Billion |
+33.40% |
| 2013-12-31 | ₩1.35 Trillion ≈ $917.43 Million |
-15.95% |
| 2012-12-31 | ₩1.61 Trillion ≈ $1.09 Billion |
+36.34% |
| 2011-12-31 | ₩1.18 Trillion ≈ $800.60 Million |
+3.46% |
| 2010-12-31 | ₩1.14 Trillion ≈ $773.85 Million |
+10.43% |
| 2009-12-31 | ₩1.03 Trillion ≈ $700.79 Million |
+57.21% |
| 2008-12-31 | ₩657.78 Billion ≈ $445.77 Million |
+20.92% |
| 2007-12-31 | ₩544.00 Billion ≈ $368.66 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Tongyang Life's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1789.1% over the analyzed period, indicating profitable operations and earnings retention.
Tongyang Life Net Assets Breakdown (December 2025)
Tongyang Life net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩1.62 Trillion | 104.53% |
| Total Equity | ₩1.55 Trillion | 100.00% |
Tongyang Life Competitors by Market Cap
The table below lists competitors of Tongyang Life ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
|
$872.56 Million |
|
Hangzhou Sunrise Technology Co Ltd
SHE:300360
|
$872.80 Million |
|
Blacksky Technology Inc
NYSE:BKSY
|
$872.93 Million |
|
Luye Pharma Group Ltd
F:LUP
|
$873.29 Million |
|
Addnode Group AB (publ)
ST:ANOD-B
|
$872.44 Million |
|
Bank Sinarmas Tbk
JK:BSIM
|
$872.24 Million |
|
Southside Bancshares, Inc.
NASDAQ:SBSI
|
$871.72 Million |
|
Pentamaster Corporation Bhd
KLSE:7160
|
$871.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tongyang Life's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,969,113,000,000 to 1,548,875,000,000, a change of -420,238,000,000 (-21.3%).
- Net income of 124,494,000,000 contributed positively to equity growth.
- Dividend payments of 22,466,000,000 reduced retained earnings.
- Other factors decreased equity by 522,266,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩124.49 Billion | +8.04% |
| Dividends Paid | ₩22.47 Billion | -1.45% |
| Other Changes | ₩-522.27 Billion | -33.72% |
| Total Change | ₩- | -21.34% |
Book Value vs Market Value Analysis
This analysis compares Tongyang Life's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.83x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.53x to 0.83x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩15502.92 | ₩8250.00 | x |
| 2018-12-31 | ₩14570.03 | ₩8250.00 | x |
| 2019-12-31 | ₩16689.59 | ₩8250.00 | x |
| 2020-12-31 | ₩19841.67 | ₩8250.00 | x |
| 2021-12-31 | ₩19530.11 | ₩8250.00 | x |
| 2022-12-31 | ₩31179.48 | ₩8250.00 | x |
| 2023-12-31 | ₩18628.30 | ₩8250.00 | x |
| 2024-12-31 | ₩12626.95 | ₩8250.00 | x |
| 2025-12-31 | ₩9924.70 | ₩8250.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tongyang Life utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.04%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.33%
- • Asset Turnover: 0.08x
- • Equity Multiplier: 22.82x
- Recent ROE (8.04%) is above the historical average (7.92%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 15.19% | 3.58% | 0.28x | 15.03x | ₩27.72 Billion |
| 2008 | 5.05% | 1.32% | 0.27x | 14.16x | ₩-31.98 Billion |
| 2009 | 10.29% | 3.67% | 0.26x | 10.87x | ₩2.98 Billion |
| 2010 | 14.39% | 4.38% | 0.29x | 11.45x | ₩49.48 Billion |
| 2011 | 8.34% | 2.49% | 0.27x | 12.57x | ₩-19.36 Billion |
| 2012 | 9.78% | 3.15% | 0.28x | 11.08x | ₩-3.47 Billion |
| 2013 | 9.43% | 3.84% | 0.18x | 13.50x | ₩-7.61 Billion |
| 2014 | 9.28% | 4.05% | 0.20x | 11.53x | ₩-12.70 Billion |
| 2015 | 8.03% | 3.49% | 0.20x | 11.51x | ₩-38.62 Billion |
| 2016 | 0.66% | 0.18% | 0.25x | 14.74x | ₩-169.29 Billion |
| 2017 | 7.86% | 3.02% | 0.21x | 12.56x | ₩-51.62 Billion |
| 2018 | 2.41% | 1.04% | 0.16x | 14.06x | ₩-172.32 Billion |
| 2019 | 4.43% | 2.06% | 0.16x | 13.05x | ₩-144.90 Billion |
| 2020 | 4.16% | 2.20% | 0.16x | 11.72x | ₩-180.67 Billion |
| 2021 | 9.05% | 5.05% | 0.15x | 12.19x | ₩-28.77 Billion |
| 2022 | -0.23% | -0.64% | 0.05x | 7.17x | ₩-497.32 Billion |
| 2023 | 8.26% | 9.58% | 0.08x | 11.32x | ₩-50.57 Billion |
| 2024 | 15.96% | 12.72% | 0.07x | 17.54x | ₩117.38 Billion |
| 2025 | 8.04% | 4.33% | 0.08x | 22.82x | ₩-30.39 Billion |
Industry Comparison
This section compares Tongyang Life's net assets metrics with peer companies in the Insurance - Life industry.
Industry Context
- Industry: Insurance - Life
- Average net assets among peers: $5,242,178,103,910
- Average return on equity (ROE) among peers: 3.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tongyang Life (082640) | ₩2.34 Trillion | 15.19% | 14.10x | $872.53 Million |
| Samsung Life (032830) | $5.81 Trillion | 0.00% | 11.59x | $28.54 Billion |
| Mirae Asset Life Insurance Co Ltd (085620) | $4.09 Trillion | 3.05% | 7.57x | $1.64 Billion |
| Hanwha Life (088350) | $5.83 Trillion | 7.21% | 9.80x | $1.99 Billion |
About Tongyang Life
Tong Yang Life Insurance Co., Ltd. engages in the life insurance business in South Korea. The company also offers death, illness, accident compensation insurance and child insurance services; and retirement pension services and asset management services. It provides its insurance services directly and through general agencies, as well as through 5 business units. Tong Yang Life Insurance Co., Ltd… Read more